A phase II, III clinical trial to assess immunogenicity, reactogenicity and safety of the measles, rubella vaccine, produced by Bio-Manguinhos
Autor: | Kleber Luz, Eliane Matos dos Santos, Maria de Lourdes de Sousa Maia, Luiz Antonio Bastos Camacho, Ricardo Cristiano Brum, Patrícia Mouta Nunes de Oliveira, Tania Petraglia, Centro de Pesquisas Clinicas. São Paulo, Sp, Brasil., Janaina Reis Xavier, Deborah Araújo da Conceição, Clara Lucy |
---|---|
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Annals of the V ISI. |
Databáze: | OpenAIRE |
Externí odkaz: |